Log in

you haven't confirmed your email address yet. resend confirmation email

Forget your password? Reset password

Enter Phone Number

Enter the code

Almost done!

We just sent a four digit code to your mobile number. Enter it here to log in!

Didn't receive the code?Re-send
Or log in with your password instead

or register with

No apps configured. Please contact your administrator.

Don't have an account? Register here.

Join the community

I have read and understand the oneSCDvoice privacy policy and terms of use, and I confirm that I am over 12 years old.

Almost done!

We just sent a four digit code to your mobile number. Enter it here to log in!

Please Wait!!!

Didn't receive the code?Re-send
Or log in with your password instead

or register with

No apps configured. Please contact your administrator.

Already have an account? Log in.

Social Wall
Trusted Resources
SCD Education

Or register here

Social Wall
Trusted Resources
SCD Education
My Account

contact us

have a question, issue or just some feedback for us? we're here for you.

what can we help you with?

let us know how we can help

suggest a poll

you must have an account to suggest polls.

join now

DISCLAIMER

The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.

compose your message

to*

from*

subject

message

message sent

email sent successfully

Trusted Resources: News & Events

Latest announcements and gatherings

Clinical Trials and Research
Spotlight
Business
People
Happenings

Back to News & Events / Clinical Trials And Research

Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients With Sickle Cell Disease Using Altemia Capsules

Sancilio Pharmaceuticals Company, Inc. (SPCI) today announced the completion of enrollment of our clinical trial evaluating AltemiaTM, an oral therapy for pediatric patients with Sickle Cell Anemia (SCA) and Sickle Cell Disease (SCD). The SCOT Trial is a double-blind, placebo-controlled, dose-finding, multi-center study to evaluate the efficacy and safety of AltemiaTM in pediatric patients aged 5-17 years old. This trial is conducted under US IND 125274.

“The completion of enrollment in this study represents an important milestone for SPCI and our lead program for SCA and SCD,” said Dr. Fred Sancilio, President and Chief Executive Officer of SPCI. “We are very encouraged by the high retention rate and adherence to treatment seen thus far in the study. This study will further our understanding of the impact of AltemiaTM on Sickle Cell Disease.”

Sancilio Pharmaceuticals Company, Inc. Announces Completion Of Enrollment In The SCOT Trial In Pediatric Patients With Sickle Cell Disease Using Altemia Capsules

Source: http://www.prnewswire.com/news-releases/sancilio-pharmaceuticals-company-inc-announces-completion-of-enrollment-in-the-scot-trial-in-pediatric-patients-with-sickle-cell-disease-using-altemia-capsules-300494609.html

Discuss in Social Wall

Twitter

Share to SCDteam

+myBinder

send a message

send to:
subject:
message:

edit tags:

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Log in

Enter the code

Join the community

Trusted Resources Home

Education & Research

People & Places

News & Events

Videos & Visuals

Community Center

Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients With Sickle Cell Disease Using Altemia Capsules

Related Content

Powered by

Log in

Enter Phone Number

Enter the code

Join the community

Trusted Resources Home

Education & Research

People & Places

News & Events

Videos & Visuals

Community Center

Trusted Resources: News & Events

Latest announcements and gatherings

Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients With Sickle Cell Disease Using Altemia Capsules

Related Content

Powered by

Support for this site is provided by